TP53 and neoplasm: However, by utilizing co-existent conditional KrasG12D activation and Trp53 KO models, we show that this tumor suppressor role is not entirely dependent on this cell-intrinsic cell cycle arrest pathway because heightened tumor burden and poorer survival were observed in Tlr2−/− mice regardless of Trp53 status.